Treatment of corticosteroid refractory immune checkpoint inhibitor myocarditis with Infliximab: a case series

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2057-3804
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Treatment of corticosteroid refractory immune checkpoint inhibitor myocarditis with Infliximab: a case series ; volume:7 ; number:1 ; day:30 ; month:3 ; year:2021 ; pages:1-8 ; date:12.2021
Cardio-Oncology ; 7, Heft 1 (30.3.2021), 1-8, 12.2021

Urheber
Zhang, Robert S.
Padegimas, Allison
Murphy, Kathleen M.
Evans, Peter T.
Peters, Carli J.
Domenico, Christopher M.
Vidula, Mahesh K.
Mather, Paul J.
Cevasco, Marisa
Cohen, Roger B.
Carver, Joseph R.
O’Quinn, Rupal P.
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1186/s40959-021-00095-x
URN
urn:nbn:de:101:1-2021052519220037791130
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 11:00 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Zhang, Robert S.
  • Padegimas, Allison
  • Murphy, Kathleen M.
  • Evans, Peter T.
  • Peters, Carli J.
  • Domenico, Christopher M.
  • Vidula, Mahesh K.
  • Mather, Paul J.
  • Cevasco, Marisa
  • Cohen, Roger B.
  • Carver, Joseph R.
  • O’Quinn, Rupal P.
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Steroid-Refractory Myocarditis Induced by Immune Checkpoint Inhibitor Responded to Infliximab: Report of Two Cases and Literature Review

Steroid-Refractory Myocarditis Induced by Immune Checkpoint Inhibitor Responded to Infliximab: Report of Two Cases and Literature Review

Infliximab Induction Strategies in Corticosteroid-Refractory Acute Severe Ulcerative Colitis: A Case Series and Literature Review

Infliximab Induction Strategies in Corticosteroid-Refractory Acute Severe Ulcerative Colitis: A Case Series and Literature Review

Smoldering myocarditis following immune checkpoint blockade

Smoldering myocarditis following immune checkpoint blockade

Refractory right ventricular myocarditis induced by immune checkpoint inhibitor despite therapy cessation and immune suppression

Refractory right ventricular myocarditis induced by immune checkpoint inhibitor despite therapy cessation and immune suppression

Refractory multisystem sarcoidosis involving pelvic bone responding to infliximab

Refractory multisystem sarcoidosis involving pelvic bone responding to infliximab

Infliximab therapy in refractory sarcoidosis: a multicenter real-world analysis

Infliximab therapy in refractory sarcoidosis: a multicenter real-world analysis

Steroid-Refractory Acute Severe Ulcerative Colitis in Infliximab-Experienced Patients

Steroid-Refractory Acute Severe Ulcerative Colitis in Infliximab-Experienced Patients

ANGPTL2 promotes immune checkpoint inhibitor-related murine autoimmune myocarditis

ANGPTL2 promotes immune checkpoint inhibitor-related murine autoimmune myocarditis

Infliximab for treatment-refractory transverse myelitis following immune therapy and radiation

Infliximab for treatment-refractory transverse myelitis following immune therapy and radiation

Influenza vaccination and myocarditis among patients receiving immune checkpoint inhibitors

Influenza vaccination and myocarditis among patients receiving immune checkpoint inhibitors

Infliximab in chronic non-infectious paediatric uveitis refractory to previous biologic therapy

Infliximab in chronic non-infectious paediatric uveitis refractory to previous biologic therapy

Clinical and pathological characteristics of immune checkpoint inhibitor-related fulminant myocarditis

Clinical and pathological characteristics of immune checkpoint inhibitor-related fulminant myocarditis

Verbundene Objekte